Technology
Lithuania’s Biomatter raises $18M for AI enzyme design and a US push
Vilnius-based Biomatter raised $18M led by Astanor for AI enzyme design. It names AstraZeneca, BASF and Sanofi as customers and plans a lab in 2027.